Add-On Daclizumab Treatment May Be Better In Reducing Multiple Sclerosis Disease Activity Than Interferon Beta Alone
Links shared publicly online about this topic.
- 1,378total visits
Add-On Daclizumab Treatment May Be Better In Reducing Multiple Sclerosis Disease Activity Than Interferon Beta Alone
An article published Online First and in the April edition of The Lancet Neurology reports that add-on daclizumab treatment might reduce multiple sclerosis disease activity more than standa
View full resource at medicalnewstoday.com
Tags: Neurology, Multiple Sclerosis, Disease and Condition
Most Recently Shared on February 16, 2010 at 1:08 pm By:
Add-On Daclizumab Treatment May Be Better In Reducing Multiple Sclerosis Disease Activity Than Interferon Beta Alone http://mnt.to/3xG5
Also Shared By:
Advertisement
MNT Health News
@mnt_healthnews
Add-On Daclizumab Treatment May Be Better In Reducing Multiple Sclerosis Disease Activity Than Interferon Beta Alone http://mnt.to/3xG5
1 year ago...